Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to BedsideTolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityGenetic disorders coupled to ROS deficiencyImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerAn Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer CellsBig brains, meat, tuberculosis, and the nicotinamide switches: co-evolutionary relationships with modern repercussions?Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?Dendritic cell-secreted lipocalin2 induces CD8+ T-cell apoptosis, contributes to T-cell priming and leads to a TH1 phenotype.IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.The role of dendritic cells in tissue-specific autoimmunity.Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.The immunobiology of the mammalian epididymis: the black box is now open!Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum.The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseasesThe control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilingsInterleukin-4 Inhibits Regulatory T Cell Differentiation through Regulating CD103+ Dendritic Cells.The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs.Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer ImmunityBreaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface.The IDO-AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection.Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.Immunological Investigations. Letter from the editor.The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.The role of Staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.
P2860
Q26746104-A7DC8E11-6DF5-4AA6-AE48-BD8128BC2E85Q26764858-9D17CB91-A9A2-457E-B04D-F7ED47E244B0Q26778646-92011478-779F-4C90-92D3-CC496BF349AAQ26785900-DCF7ADD8-1F1D-4EBA-BAB7-5D0B50A13D48Q26799545-3D43B6F5-591F-437D-9430-06E07AABD58AQ26996829-285AD4FC-3C27-4E0D-B900-29A957FECF2BQ28547142-D9CE78F7-A371-4F4C-999E-0C91D7C9E990Q28661643-4CE14F5E-31A4-48CB-B9A6-C83A03425E12Q30411008-9E399B01-6EF8-4969-8B3F-45DA95260937Q33882653-7F72CF13-4EDF-4A20-9E49-76EC4A6A9B98Q34401702-0BABA629-D95F-4A82-B2BB-76B4CA78E28AQ34422017-5DE12EA6-81A8-4D8A-B645-0D243ABEF5EBQ35122841-DE1C7AB6-68AD-46F1-8DD8-4A4FF45A4016Q35579203-5A963F64-D322-4D5A-BCD7-85F1D5B8FA22Q35799094-C1BC7E06-1564-4D9F-9482-A701ABB46AE6Q36172617-D295FCD5-A4EE-49F1-B60B-20646C21BBFAQ36984717-920F581F-3E15-4DB4-9F9C-B913A85F9EF2Q37249406-D4016808-2B44-4DA9-9240-E5C6DD4FA533Q37677838-960574ED-1C94-4B02-898A-CC3400861D9FQ37678976-D94F25D9-0246-4F49-8F9B-B520A0C5BE13Q37711667-5AE47C2E-8BA5-42AA-8459-63C2A1D7BFE5Q38174601-DA74C5C4-C266-4003-9B19-9C25A76B2C73Q38185156-4229BF3D-3A5C-4201-9DBB-9455F1EC8486Q38239650-9B8F9F16-D167-41AF-AD71-D02527049A2FQ38774994-C817ED51-2451-44D8-A0BE-9B280EEE5334Q39126900-D6D27E3F-B6E2-471E-A419-B7D3AC66FA92Q40101155-82B0248D-8517-44AF-944E-FA47955DF190Q41569221-0D3DC7CB-DEE9-4DE0-AFEC-6241166D291CQ42378527-6CE19A65-5C46-47A6-84DD-C36E95AB55A0Q42747099-77532C25-0F3A-4EEA-AF4B-497627D664CFQ44817360-E6E62F10-F172-4DF6-B249-D6CC63B82235Q48047320-62E33F27-DDEE-4C34-8BA7-F6615D9DDE0BQ48194798-B856E31E-E35F-4257-94FC-BE817D37FECEQ51165149-713793D0-208C-4DC0-901C-A32DC33580FAQ51764522-124DBDBF-07E0-4D01-A00D-865DD5C8B3DBQ52121093-7D3D4A14-FB23-4EA6-BB99-67CD852EE509Q52668325-41648CAB-B0ED-4902-9046-AFD22F8886C3Q54417366-CB68B422-E424-4AA6-9F00-A8B1E8DE1ECDQ55003884-A66B8838-9462-4BFE-9CD9-34FCAC96DE59Q55381445-EBACBCEB-3790-4655-8D38-A1FBAF07E0CD
P2860
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
@en
type
label
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
@en
prefLabel
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
@en
P2860
P1476
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
@en
P2093
Jamie L Harden
Nejat K Egilmez
P2860
P304
P356
10.3109/08820139.2012.676122
P577
2012-01-01T00:00:00Z